The pharmacokinetics of cefuroxime axetil in the sick elderly patient.
The pharmacokinetics of cefuroxime axetil (RS3 formulation) were studied in 20 elderly patients following admission for lower respiratory or urinary tract infection. The mean age was 83.9 years. A 12-hourly dose of 250 mg was given for five days. The mean time to attain maximum serum concentration was 3.2 h with a mean peak concentration of 8.5 mg/l. The mean serum elimination half-life was 3.5 h and the AUC0-infinity 60.4 mg/h.l. There was no accumulation of the drug in the patients studied after five days treatment. The data suggest that the standard dosage regimen is adequate in the sick elderly patient.
Ridgway
E
E
Department of Microbiology, Whittington Hospital, London, UK.
Stewart
K
K
Rai
G
G
Kelsey
M C
MC
Bielawska
C
C
D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D002444:Cefuroxime / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D012141:Respiratory Tract Infections / Q000378:metabolism*; D014552:Urinary Tract Infections / Q000378:metabolism*
D002444:Cefuroxime; C040738:cefuroxime axetil